402 related articles for article (PubMed ID: 35735625)
1. Current and Future Perspectives of Cell-Free DNA in Liquid Biopsy.
Liu S; Wang J
Curr Issues Mol Biol; 2022 Jun; 44(6):2695-2709. PubMed ID: 35735625
[TBL] [Abstract][Full Text] [Related]
2. Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review).
Finotti A; Allegretti M; Gasparello J; Giacomini P; Spandidos DA; Spoto G; Gambari R
Int J Oncol; 2018 Oct; 53(4):1395-1434. PubMed ID: 30085333
[TBL] [Abstract][Full Text] [Related]
3. Cell Free DNA as an Evolving Liquid Biopsy Biomarker for Initial Diagnosis and Therapeutic Nursing in Cancer- An Evolving Aspect in Medical Biotechnology.
Ray SK; Mukherjee S
Curr Pharm Biotechnol; 2022; 23(1):112-122. PubMed ID: 33308128
[TBL] [Abstract][Full Text] [Related]
4. The Current Landscape of Glioblastoma Biomarkers in Body Fluids.
Zanganeh S; Abbasgholinejad E; Doroudian M; Esmaelizad N; Farjadian F; Benhabbour SR
Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568620
[TBL] [Abstract][Full Text] [Related]
5. Liquid Biopsy: An Evolving Paradigm for Non-invasive Disease Diagnosis and Monitoring in Medicine.
Adhit KK; Wanjari A; Menon S; K S
Cureus; 2023 Dec; 15(12):e50176. PubMed ID: 38192931
[TBL] [Abstract][Full Text] [Related]
6. Cell-Free DNA Variant Sequencing Using CTC-Depleted Blood for Comprehensive Liquid Biopsy Testing in Metastatic Breast Cancer.
Keup C; Storbeck M; Hauch S; Hahn P; Sprenger-Haussels M; Tewes M; Mach P; Hoffmann O; Kimmig R; Kasimir-Bauer S
Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30781720
[TBL] [Abstract][Full Text] [Related]
7. Advances in liquid biopsy using circulating tumor cells and circulating cell-free tumor DNA for detection and monitoring of breast cancer.
Zhang X; Ju S; Wang X; Cong H
Clin Exp Med; 2019 Aug; 19(3):271-279. PubMed ID: 31190187
[TBL] [Abstract][Full Text] [Related]
8. Isolation and enrichment of circulating biomarkers for cancer screening, detection, and diagnostics.
Hyun KA; Kim J; Gwak H; Jung HI
Analyst; 2016 Jan; 141(2):382-92. PubMed ID: 26588824
[TBL] [Abstract][Full Text] [Related]
9. Liquid biopsy tracking of lung tumor evolutions over time.
Russo A; De Miguel Perez D; Gunasekaran M; Scilla K; Lapidus R; Cooper B; Mehra R; Adamo V; Malapelle U; Rolfo C
Expert Rev Mol Diagn; 2019 Dec; 19(12):1099-1108. PubMed ID: 31608732
[No Abstract] [Full Text] [Related]
10. A review on the impact of single-stranded library preparation on plasma cell-free diversity for cancer detection.
Cheng JC; Swarup N; Wong DTW; Chia D
Front Oncol; 2024; 14():1332004. PubMed ID: 38511142
[TBL] [Abstract][Full Text] [Related]
11. Current Status and Future Perspectives of Liquid Biopsy in Small Cell Lung Cancer.
Mondelo-Macía P; García-González J; León-Mateos L; Castillo-García A; López-López R; Muinelo-Romay L; Díaz-Peña R
Biomedicines; 2021 Jan; 9(1):. PubMed ID: 33430290
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic performance of various liquid biopsy methods in detecting colorectal cancer: A meta-analysis.
Zhu Y; Yang T; Wu Q; Yang X; Hao J; Deng X; Yang S; Gu C; Wang Z
Cancer Med; 2020 Aug; 9(16):5699-5707. PubMed ID: 32628360
[TBL] [Abstract][Full Text] [Related]
13. Finding new cancer epigenetic and genetic biomarkers from cell-free DNA by combining SALP-seq and machine learning.
Liu S; Wu J; Xia Q; Liu H; Li W; Xia X; Wang J
Comput Struct Biotechnol J; 2020; 18():1891-1903. PubMed ID: 32774784
[TBL] [Abstract][Full Text] [Related]
14. Liquid Biopsy for Promising Non-invasive Diagnostic Biomarkers in Parasitic Infections.
Ozturk EA; Caner A
Acta Parasitol; 2022 Mar; 67(1):1-17. PubMed ID: 34176040
[TBL] [Abstract][Full Text] [Related]
15. The role of circulating free DNA in the management of NSCLC.
Esposito Abate R; Pasquale R; Fenizia F; Rachiglio AM; Roma C; Bergantino F; Forgione L; Lambiase M; Sacco A; Piccirillo MC; Morabito A; Normanno N
Expert Rev Anticancer Ther; 2019 Jan; 19(1):19-28. PubMed ID: 30462523
[TBL] [Abstract][Full Text] [Related]
16. Liquid biopsy in CNS tumors: Current status & future perspectives.
Husain N; Husain A; Mishra S; Srivastava P
Indian J Pathol Microbiol; 2022 May; 65(Supplement):S111-S121. PubMed ID: 35562141
[TBL] [Abstract][Full Text] [Related]
17. Detection of EGFR Mutations in cfDNA and CTCs, and Comparison to Tumor Tissue in Non-Small-Cell-Lung-Cancer (NSCLC) Patients.
Liu HE; Vuppalapaty M; Wilkerson C; Renier C; Chiu M; Lemaire C; Che J; Matsumoto M; Carroll J; Crouse S; Hanft VR; Jeffrey SS; Di Carlo D; Garon EB; Goldman J; Sollier E
Front Oncol; 2020; 10():572895. PubMed ID: 33117705
[TBL] [Abstract][Full Text] [Related]
18. Liquid biopsy in ovarian cancer: the potential of circulating miRNAs and exosomes.
Giannopoulou L; Zavridou M; Kasimir-Bauer S; Lianidou ES
Transl Res; 2019 Mar; 205():77-91. PubMed ID: 30391474
[TBL] [Abstract][Full Text] [Related]
19. Liquid biopsy in breast cancer: A comprehensive review.
Alimirzaie S; Bagherzadeh M; Akbari MR
Clin Genet; 2019 Jun; 95(6):643-660. PubMed ID: 30671931
[TBL] [Abstract][Full Text] [Related]
20. Bioinformatics Analysis for Circulating Cell-Free DNA in Cancer.
Huang CC; Du M; Wang L
Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31212602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
